Due to its small size which can facilitate both the genetic manipulation and the CAR expression, scFv has been used extensively as the antigen-recognition domain in many CARs. The scFv determines the CAR antigen specificity and makes the CAR-T cells bind target cells in a MHC-independent, non-restricted manner with the specificity and affinity similar to the antibody which it is derived from.